Seeing Is Believing
Currently out of the existing stock ratings of Elmar Kraus, 15 are a BUY (62.5%), 9 are a HOLD (37.5%).
Analyst Elmar Kraus, currently employed at DZ BANK, carries an average stock price target met ratio of 79.63% that have a potential upside of 18.63% achieved within 256 days. Previously, Elmar Kraus worked at STIFEL.
Elmar Kraus’s has documented 48 price targets and ratings displayed on 9 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on ABBV, AbbVie at 01-May-2024.
Analyst best performing recommendations are on ABBV (ABBVIE).
The best stock recommendation documented was for LLY (ELI LILLY AND COMPANY) at 1/21/2022. The price target of $291 was fulfilled within 75 days with a profit of $56.47 (24.08%) receiving and performance score of 3.21.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold
$149
$2.43 (1.66%)
$152
6 days ago
(10-Oct-2025)
23/47 (48.94%)
$2.43 (1.66%)
277
Hold
22 days ago
(24-Sep-2025)
7/32 (21.88%)
$112.06 (70.95%)
255
Hold
$118
$-28.57 (-19.49%)
$115
2 months 2 days ago
(14-Aug-2025)
0/2 (0%)
$-16.94 (-12.55%)
Buy
$213
$66.43 (45.32%)
$205
3 months 19 days ago
(27-Jun-2025)
39/69 (56.52%)
$86.92 (68.94%)
121
Buy
$187
$40.43 (27.58%)
$187
3 months 20 days ago
(26-Jun-2025)
9/23 (39.13%)
$60.08 (47.34%)
260
What Year was the first public recommendation made by Elmar Kraus?